Hematology/Oncology

Top Story

Bisphosphonates improve breast cancer survival in postmenopausal women

September 4, 2015

Adjuvant treatment with bisphosphonates reduced the rate of breast cancer recurrence in the bone and improved breast-cancer survival among women who were postmenopausal at treatment initiation, according to the results of a meta-analysis.

“Currently, bisphosphonates are mainly used to reduce bone loss and fractures in postmenopausal women and to reduce bone complications in advanced cancer patients,” Robert Coleman, MBBS, MD, FRCP, professor of medical oncology at University of Sheffield, said in a press release.

In the Journals

Extent of lymphadenectomy may not influence survival in esophageal cancer

September 3, 2015
The number of lymph nodes removed during lymphadenectomy may not influence 5-year all-cause or disease-specific survival among patients with esophageal cancer, according…
In the Journals

Simulation model provides more accurate estimate of cancer progression in Barrett's esophagus

September 3, 2015
Simulation modeling revealed that the lower estimates of the rate of progression from Barrett’s esophagus to esophageal adenocarcinoma from population-based…
In the Journals

Imetelstat demonstrates safety, efficacy for essential thrombocythemia

September 3, 2015
Patients with essential thrombocythemia who did not respond to or had unacceptable side effects from previous therapies experienced rapid and durable hematologic and…

Novartis receives EU approval for combination treatment of metastatic melanoma

September 3, 2015
Novartis has received European Commission approval for the combination of Tafinlar and Mekinist to treat metastatic melanoma with a BRAF V600 mutation, according to a…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
morganatic-roan morganatic-roan